Stocktoria
NEPHROS INC NEPH
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2004-09-21
NEPHROS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $18.8M | $14.2M | $14.2M | $10.0M | $10.2M |
| Gross profit | $11.6M | $8.7M | $8.4M | $4.7M | $5.6M |
| R&D expense | $1.3M | $906,000 | $873,000 | $1.3M | $1.5M |
| SG&A expense | $9.0M | $7.7M | $8.9M | $7.6M | $7.2M |
| Operating income | $1.1M | $6,000 | -$1.6M | -$4.3M | -$3.3M |
| Interest expense | — | — | $2,000 | $20,000 | $41,000 |
| Income tax | $12,000 | $15,000 | $0 | $0 | $0 |
| Net income | $1.2M | $74,000 | -$1.6M | — | -$3.9M |
| EPS (diluted) | $0.11 | $0.01 | $-0.15 | $-0.73 | — |
| Operating cash flow | $1.6M | -$500,000 | $827,000 | -$3.2M | -$1.4M |
| Free cash flow | — | -$555,000 | $752,000 | -$3.4M | -$1.5M |
| Cash & equivalents | $5.4M | $3.8M | $4.3M | $3.6M | $7.0M |
| Inventory | $3.2M | $2.6M | $2.5M | $3.2M | $4.5M |
| Total assets | $13.6M | $11.2M | $11.9M | $11.0M | $17.6M |
| Total liabilities | $3.4M | $2.6M | $3.5M | $2.1M | $2.9M |
| Shareholders' equity | $10.2M | $8.6M | $8.4M | $8.9M | $14.7M |
Source: SEC EDGAR filings · CIK 0001196298 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.